Dight, Jack2024-06-112024-06-112024-02-02Dight, J., 2024. α1-adrenoceptor antagonists and 5α-reductase inhibitors for urinary tract symptoms in benign prostatic hyperplasia. Journal of Paramedic Practice, 16 (2), 1-9.1759-13762041-945710.12968/jpar.2024.16.2.49http://hdl.handle.net/20.500.12417/1780Benign prostatic hyperplasia is a condition that develops in the majority of men and is by some estimates is the most prevalent of all minor ailments. A healthily functioning prostate is important for the workings of the male reproductive and urinary systems. The most frequently prescribed first-line pharmacological treatments for lower urinary tract symptoms attributed to benign prostatic hyperplasia are α1-adrenoceptor antagonists and 5α-reductase inhibitors; surgery can also be carried out. Expert consensus and a strong body of evidence show these drugs are safe and effective. However, they come with a variety of side-effects so patients' priorities and lifestyles will influence pharmacological management. Abstract published with permission.enEmergency Medical ServicesNocturiaProstateLower Urinary Tract SymptomsHyperplasia